The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Atossa Therapeutics, Inc(NASDAQ:ATOS) 
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cance...
Website: http://www.atossagenetics.com
Founded: 2008
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
Atossa Therapeutics Days Payable Outstanding ttm (DPO)
Atossa Therapeutics Days Inventory Outstanding ttm (DIO)
Atossa Therapeutics Op Cashflow Per Share ttm
Atossa Therapeutics Free Cashflow Per Share ttm
Atossa Therapeutics Cash Per Share ttm
Atossa Therapeutics (GAAP) P/E ratio ttm
Atossa Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.